Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HepNet pilot trial: Sofosbuvir for chronic hepatitis E (SofE)
2017-000403-24Phase 2Completed
- Sponsor
- Hannover Medical School
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sofosbuvir in hepatitis E (HEV), sponsored by Hannover Medical School. Primary endpoint: HEV RNA negativity at week 24. Started Sep 2017; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis E (HEV)
Beyond the preview
Go deeper on 2017-000403-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000403-24.